I fear Hahn is setting the stage for the FDA to approve the drugs by Regeneron and Eli Lilly following President Trump’s comments regarding “approval.” I hope the FDA will be fair to any COVID19 therapeutic that shows statistically significant improvement and is safe, including leronlimab, when data from the S/C does just that. But the FDA has a history of favoring BP and not small biotechs, but they may not be able to if the data is clear. NP has some type of connection to Fox News so good, clear data will not be isolated to a PR, but shared in national television.